NCT05969821 - Clonal Hematopoiesis of Immunological Significance | Biotech Hunter

Enrollment

1,000

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2045

Study Completion Date

September 30, 2045

Conditions

Immune System DiseasesAutoimmune DiseasesInflammationAutoinflammatory DiseasesVexas SyndromeHematopoiesis ClonalClonal Hematopoiesis of Indeterminate PotentialHematologic DiseasesMyelodysplastic-Myeloproliferative DiseasesLeukemia Myelomonocytic ChronicMyelodysplastic SyndromesMyeloproliferative DisordersLymphoproliferative DisordersLymphomaLeukemiaMonoclonal Gammopathy of Undetermined Significance

Interventions

OTHER

observational cohort study

All Listed Sponsors

collaborator

Sorbonne University

OTHER

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

Club MINHEMON (MEDECINE INTERNE, HEMATO ET ONCO)

UNKNOWN

lead

Assistance Publique - Hôpitaux de Paris

OTHER